[go: up one dir, main page]

FI922542L - Fettsyrakompositioner - Google Patents

Fettsyrakompositioner Download PDF

Info

Publication number
FI922542L
FI922542L FI922542A FI922542A FI922542L FI 922542 L FI922542 L FI 922542L FI 922542 A FI922542 A FI 922542A FI 922542 A FI922542 A FI 922542A FI 922542 L FI922542 L FI 922542L
Authority
FI
Finland
Prior art keywords
fatty acid
acid compositions
compositions
fatty
acid
Prior art date
Application number
FI922542A
Other languages
English (en)
Other versions
FI103867B (fi
FI103867B1 (fi
FI922542A0 (fi
Inventor
David Frederick Horrobin
Yung-Sheng Huang
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of FI922542A0 publication Critical patent/FI922542A0/fi
Publication of FI922542L publication Critical patent/FI922542L/fi
Application granted granted Critical
Publication of FI103867B publication Critical patent/FI103867B/fi
Publication of FI103867B1 publication Critical patent/FI103867B1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Edible Oils And Fats (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Logic Circuits (AREA)
  • Amplifiers (AREA)
FI922542A 1991-06-03 1992-06-02 Menetelmä di-linoleoyyli-mono-gamma-linolenyyli-glyserolia sisältävän, farmaseuttisesti käyttökelpoisen öljyn valmistamiseksi FI103867B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9111900 1991-06-03
GB919111900A GB9111900D0 (en) 1991-06-03 1991-06-03 Fatty acid compositions

Publications (4)

Publication Number Publication Date
FI922542A0 FI922542A0 (fi) 1992-06-02
FI922542L true FI922542L (fi) 1992-12-04
FI103867B FI103867B (fi) 1999-10-15
FI103867B1 FI103867B1 (fi) 1999-10-15

Family

ID=10695999

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922542A FI103867B1 (fi) 1991-06-03 1992-06-02 Menetelmä di-linoleoyyli-mono-gamma-linolenyyli-glyserolia sisältävän, farmaseuttisesti käyttökelpoisen öljyn valmistamiseksi

Country Status (20)

Country Link
US (4) US5328691A (fi)
EP (1) EP0520624B1 (fi)
JP (1) JP2704922B2 (fi)
KR (2) KR100274727B1 (fi)
AT (1) ATE136214T1 (fi)
AU (1) AU652827B2 (fi)
CA (1) CA2069600C (fi)
DE (1) DE69209571T2 (fi)
DK (1) DK0520624T3 (fi)
ES (1) ES2085567T3 (fi)
FI (1) FI103867B1 (fi)
GB (1) GB9111900D0 (fi)
GR (1) GR3019840T3 (fi)
HK (1) HK4597A (fi)
IE (1) IE75224B1 (fi)
NO (1) NO180804C (fi)
NZ (1) NZ242898A (fi)
SG (1) SG49739A1 (fi)
TW (1) TW288975B (fi)
ZA (1) ZA923913B (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
FR2706304B1 (fr) * 1993-06-15 1995-09-01 Carita Sa Utilisation des huiles de Chaulmoogra dans le domaine cosmétique et pharmaceutique, notamment en dermatologie, pour harmoniser la pigmentation de la peau.
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
EP0707850A1 (en) * 1994-09-21 1996-04-24 Scotia Holdings Plc Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5639460A (en) * 1995-06-07 1997-06-17 Raymond; Hal C. Aqueous plant extract having antiviral activity
US5959131A (en) * 1995-12-07 1999-09-28 Kraft Foods, Inc. Nutritionally superior fat for food compositions
DK0906414T4 (en) * 1996-03-28 2015-11-16 Dsm Ip Assets Bv PROCESS FOR THE PREPARATION OF A granular MICROBIAL BIOMASS AND ISOLATION OF VALUABLE COMPOUNDS THENCE
AU731785B2 (en) * 1996-03-28 2001-04-05 Gist-Brocades B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
US6255505B1 (en) 1996-03-28 2001-07-03 Gist-Brocades, B.V. Microbial polyunsaturated fatty acid containing oil from pasteurised biomass
ATE353689T1 (de) 1997-07-16 2007-03-15 Metacure Nv Einrichtung zur steuerung eines glatten muskels
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
GB9918023D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
EP1328281B1 (en) * 2000-06-27 2007-08-15 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
KR101435707B1 (ko) 2002-06-19 2014-09-01 디에스엠 아이피 어셋츠 비.브이. 미생물 세포와 미생물 오일용 파스퇴르살균 방법
WO2004012753A1 (en) * 2002-07-31 2004-02-12 Helfried Hans Rudolf Crede Pharmaceutical composition containing black cumin oil, flax oil and borago oil
US7255972B2 (en) 2002-10-23 2007-08-14 Az Electronic Materials Usa Corp. Chemically amplified positive photosensitive resin composition
JP2006524187A (ja) * 2003-01-31 2006-10-26 ザ プロクター アンド ギャンブル カンパニー 哺乳類のケラチン組織の外観を改善する手段
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
EP2324828A1 (en) 2003-08-18 2011-05-25 BTG International Limited Treatment for neurodegenerative conditions
JP2006061021A (ja) * 2004-08-24 2006-03-09 Suntory Ltd １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
JP2010042037A (ja) * 2009-11-26 2010-02-25 Suntory Holdings Ltd １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
WO2011092710A2 (en) 2010-02-01 2011-08-04 Metacure Limited Gastrointestinal electrical therapy
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
EP3546446A1 (en) 2013-11-15 2019-10-02 DS Biopharma Limited Pharmaceutically acceptable salts of polyunsaturated hydroxy fatty acids
WO2015185698A1 (en) 2014-06-04 2015-12-10 Dignity Sciences Limited Pharmaceutical compositions comprising dgla and use of same
CN107666904B (zh) 2015-03-26 2022-02-01 提贝托·布鲁泽塞 多不饱和脂肪酸的纯化组合物、其制备方法及其用途
CN113896628A (zh) 2015-05-13 2022-01-07 Ds生物制药有限公司 包含15-氧代-epa或15-氧代-dgla的组合物及其制备和使用方法
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172149A (en) * 1978-01-30 1979-10-23 Westwood Pharmaceuticals, Inc. Method for treating living skin exhibiting excessive sebum secretion
DE2942021A1 (de) * 1979-10-17 1981-04-30 Bristol Myers Co Dermatologisches mittel
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
US5011855A (en) * 1982-04-16 1991-04-30 Nestec S.A. Cosmetic and dermatological compositions containing γ-linolenic acid
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
DE3366530D1 (en) * 1982-04-29 1986-11-06 Efamol Ltd Pharmaceutical composition
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2569347B1 (fr) * 1984-08-22 1987-10-23 Mollet Marc Composition lipidique favorisant la pousse des phaneres et produits cosmetiques en renfermant
GB8516906D0 (en) * 1985-07-04 1985-08-07 Efamol Ltd Pharmaceutical & dietary composition
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
FR2588187B1 (fr) * 1985-10-07 1989-04-14 Rochas Parfums Nouvelles compositions cosmetiques ou dermatologiques riches en acides gras essentiels presents a la fois sous forme de triglycerides et sous forme libre ou salifiee
JPS6284041A (ja) * 1985-10-08 1987-04-17 Nitto Electric Ind Co Ltd γ−リノレン酸含有包接物
JPS62187425A (ja) * 1985-10-14 1987-08-15 Michio Nakanishi リノレン酸系化合物含有組成物
SE8604117D0 (sv) * 1986-09-29 1986-09-29 Kabivitrum Ab Composition
JPH0832628B2 (ja) * 1986-12-17 1996-03-29 株式会社ミドリ十字 トリグリセリド組成物
JPS6451496A (en) * 1987-08-21 1989-02-27 Nippon Oils & Fats Co Ltd Method of refining oil containing gamma-linolenic acid
FR2623692B1 (fr) * 1987-11-30 1991-05-03 Vernin Jean Gilles Nouvelle huile dietetique
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
US5116871A (en) * 1988-09-13 1992-05-26 Efamol Holdings Plc Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis
GB9001121D0 (en) * 1990-01-18 1990-03-21 Efamol Holdings Efa compositions and therapy

Also Published As

Publication number Publication date
US5552150A (en) 1996-09-03
ATE136214T1 (de) 1996-04-15
KR100274727B1 (ko) 2000-12-15
AU652827B2 (en) 1994-09-08
DE69209571T2 (de) 1996-09-05
US5620701A (en) 1997-04-15
NZ242898A (en) 1994-12-22
DK0520624T3 (da) 1996-05-06
FI103867B (fi) 1999-10-15
SG49739A1 (en) 1998-06-15
NO922183L (no) 1992-12-04
TW288975B (fi) 1996-10-21
US5614208A (en) 1997-03-25
IE75224B1 (en) 1997-08-27
NO180804C (no) 1997-07-02
KR930000664A (ko) 1993-01-15
JPH05201924A (ja) 1993-08-10
DE69209571D1 (de) 1996-05-09
NO180804B (no) 1997-03-24
FI103867B1 (fi) 1999-10-15
GR3019840T3 (en) 1996-08-31
EP0520624A1 (en) 1992-12-30
FI922542A0 (fi) 1992-06-02
CA2069600A1 (en) 1992-12-04
CA2069600C (en) 2004-05-04
ES2085567T3 (es) 1996-06-01
JP2704922B2 (ja) 1998-01-26
EP0520624B1 (en) 1996-04-03
KR100277424B1 (ko) 2000-12-15
ZA923913B (en) 1993-02-24
GB9111900D0 (en) 1991-07-24
NO922183D0 (no) 1992-06-02
IE921663A1 (en) 1992-12-16
AU1727892A (en) 1992-12-10
US5328691A (en) 1994-07-12
HK4597A (en) 1997-01-17

Similar Documents

Publication Publication Date Title
FI922542L (fi) Fettsyrakompositioner
FI935847L (fi) L-DOPA-esterikoostumukset
DE69232467D1 (de) Antireflexionszusammensetzungen
BR9307801A (pt) Composições orais
NO934009D0 (no) Farmasoeytiske formuleringer
FI950910A0 (fi) Rasvahappojohdannaiset
BR9200112A (pt) Composicoes cataliticas
DE69221681D1 (de) Waschmittelzusammensetzungen
FI925777L (fi) Smoerjmedelskompositioner
FI950909L (fi) Rasvahappojohdannaisia
FI922582L (fi) Fettsyrabehandling
FI923865L (fi) Monoatsopigmentkompositioner
ITMI920006A0 (it) Composizioni di lubrificanti
DE69319643D1 (de) Reinigungsmittelzusammensetzungen
DK0464381T3 (da) 2-Methoximinocarboxylsyreestere
DE69316918D1 (de) Waschmittelzusammensetzungen
DE59305938D1 (de) Pyridyloxy-acrylsäureester
DE69307660D1 (de) Waschmittelzusammensetzungen
FI925775L (fi) Smoerjmedelskompositioner
DE69225449D1 (de) Waschmittelzusammensetzungen
DE59205221D1 (de) 1-Alkoxyhexatrien-2-carbonsäureester
DE69302510D1 (de) Reinigungsmittelzusammensetzungen
DE69027139D1 (de) Zusammensetzungen
MX9205489A (es) Composiciones blanqueadoras
FI884905L (fi) Pesuainekoostumukset